Literature DB >> 3986847

Effect of sulfated derivatives of chitosan on some blood coagulant factors.

S Hirano, Y Tanaka, M Hasegawa, K Tobetto, A Nishioka.   

Abstract

The effect of some sulfated derivatives of chitosan on several blood-coagulant factors was examined in comparison with those of heparin (174 units/mg). The anticoagulant activity (units/mg) with respect to activated partial thromboplastin time was 331-379 for O-sulfated N-acetylchitosan (2), 190-287 for N, O-sulfated chitosan (1), and 21-31 for sulfated O-carboxymethylchitosan (3). The activity (units/mg) with respect to thrombin time was 70-87 for 2, 44-70 for 1, and 14-22 for 3. The activity (units/mg) with respect to antithrombin activity was 4.9-9.0 for 2, 4.7-8.7 for 1, and 3.3-6.0 for 3. No anti-(factor Xa) activity was observed with 1-3. A 6-sulfate group in the hexosaminyl moiety was a main active site; although a 3-sulfate group was not essential, it promoted the activity of the 6-sulfate group. N-Sulfate was not a prerequisite for activity. The biological activities were also related to molecular weight in the sequence 2 (26,000) greater than heparin (21,000) greater than 1 (12,000) greater than 3 (540,000). For the Methylene Blue complexes, 1, but neither 2 nor 3, exhibited a negative, induced Cotton effect similar to that of heparin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3986847     DOI: 10.1016/0008-6215(85)85161-2

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  7 in total

1.  Chitin and Chitosan: Production and Application of Versatile Biomedical Nanomaterials.

Authors:  Daniel Elieh-Ali-Komi; Michael R Hamblin
Journal:  Int J Adv Res (Indore)       Date:  2016-03-01

2.  Preparation and characterization of novel silica-butyrylchitosan hybrid biomaterials.

Authors:  A P Zhu; Z Zhang; J Shen
Journal:  J Mater Sci Mater Med       Date:  2003-01       Impact factor: 3.896

3.  Sulfonation of papain-treated chitosan and its mechanism for anticoagulant activity.

Authors:  Jiraporn Suwan; Zhenqing Zhang; Boyangzi Li; Preeyanat Vongchan; Puttinan Meepowpan; Fuming Zhang; Shaker A Mousa; Shaymaa Mousa; Bhusana Premanode; Prachya Kongtawelert; Robert J Linhardt
Journal:  Carbohydr Res       Date:  2009-04-20       Impact factor: 2.104

4.  Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.

Authors:  P Hovingh; M Piepkorn; A Linker
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

5.  Antimicrobial, anticoagulant, and cytotoxic evaluation of multidrug resistance of new 1,4-dihydropyridine derivatives.

Authors:  Anis Ahamed; Ibrahim A Arif; Mohammed Mateen; Radhakrishnan Surendra Kumar; Akbar Idhayadhulla
Journal:  Saudi J Biol Sci       Date:  2018-03-06       Impact factor: 4.219

6.  Low-molecular-weight sulfonated chitosan as template for anticoagulant nanoparticles.

Authors:  Katja Heise; Mathias Hobisch; Liviu Sacarescu; Uros Maver; Josefine Hobisch; Tobias Reichelt; Marija Sega; Steffen Fischer; Stefan Spirk
Journal:  Int J Nanomedicine       Date:  2018-08-30

Review 7.  Crustacean Waste-Derived Chitosan: Antioxidant Properties and Future Perspective.

Authors:  Manikandan Muthu; Judy Gopal; Sechul Chun; Anna Jacintha Prameela Devadoss; Nazim Hasan; Iyyakkannu Sivanesan
Journal:  Antioxidants (Basel)       Date:  2021-02-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.